Effect of Transcutaneous Electrical Acupoint Stimulation on Dyspareunia
ConditionDyspareunia (Female)
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age25-35
SponsorCairo University
About this trial
Transcutaneous electrical acupoint stimulation (TEAS)was proven to stimulate the secretion of endogenous opioid peptides which are partial substitutes for the exogenous opioids stimulated by drugs in the central nervous system and can thus relieve pain. Till now there is no previous study that investigates the effect of TEAS on dyspareunia. This study will determine the effect of transcutaneous acupoint stimulation on dyspareunia.
Patients will be divided randomly into two groups equal in number: The control group will receive only topical medication. The study group will receive Acu-TENS and topical medication.
Eligibility criteria
Qualifiers
Women complain of secondary dyspareunia, diagnosed and referred by the gynecologist.
Multiparous women.
Their ages will range from 25-35 years.
Their body BMI will be less than 35 kg/m².
Disqualifiers
Pregnancy
Malignancy.
The presence of an intrauterine device, vaginal infection, or skin/mucous lesions.
Diabetes mellitus.
Trial design
Treatments tested in this trial
- Topical medication
- Transcutaneous electrical acupoint stimulation
Treatment groups
38 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov